USD10
Actions FHTX
À propos de Foghorn TherapeuticsFoghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.
USD10
Actions FHTX
À propos de Foghorn TherapeuticsFoghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.
Statistiques
FENÊTRE DE TRADING
Fermé
OUVRE À
24 mars at 13:30 UTC+0
Capitalisation boursière
281,76 M $US
PRIX D'OUVERTURE
5,06 $US
BAS (1 an)
2,94 $US
ÉLEVÉ (1 an)
6,95 $US
BAS (24 h)
4,74 $US
ÉLEVÉ (24 h)
5,11 $US
Volume (24 h)
162,48 k $US
2,33 %
Historique des prix
Time | Price | Change |
|---|---|---|
Aujourd'hui | 5,06 $US | |
1 jour | 5,02 $US | |
1 semaine | 5,02 $US | |
1 mois | 5,85 $US | |
1 an | 3,97 $US |
Une nouvelle ère de Coinbase a commencé
Rejoignez la révolution crypto avec Coinbase. Soyez parmi les premiers à accéder aux nouvelles fonctionnalités et à les essayer dès leur mise à disposition.
Créez un compte dès maintenant